The EU's Top Valsartan Lesson: Closely Examine Active Substance Manufacturing Processes

 
• By Joanne S. Eglovitch

EU report on “lessons learnt” from the valsartan crisis calls for tighter GMP controls on API suppliers.

Blood pressure
EU Lessons Learnt Report On Valsartan Crisis Focuses On Supply Chain • Source: Shutterstock

More from Manufacturing

More from Compliance